What are the Limitations of the RTS,S/AS01 Vaccine?
While the RTS,S/AS01 vaccine represents a significant advancement, it is not a silver bullet. Its efficacy varies, providing only partial protection and requiring a four-dose schedule for optimal effectiveness. Additionally, the protection it offers tends to wane over time, necessitating booster doses. Researchers are actively working on improving the efficacy and longevity of malaria vaccines.
